TPIsoftware and Yuan's General Hospital Join Forces to Revolutionize Healthcare with GenAI Digital Health Platform

TAIPEI,March 19,2025-- TPIsoftware (TWSE: 7781) and Yuan\'s General Hospital,a leading medical institution in Southern Taiwan,have collaborated to launch a digital health platform that leverages gene

Taboola Reaches 10 Years in Serving Advertising on Microsoft Properties Including MSN, Edge Browsers and Windows Experiences

Taboola Now Serves Advertising Across Microsoft Productivity Suite,Including Outlook Mail and Office 365

WEKA Expands NVIDIA Integrations and Certifications, Unveils Augmented Memory Grid at GTC 2025

Accelerates AI Reasoning With the NVIDIA AI Data Platform andAchieves New Storage Certifications for NVIDIA Cloud Partners and Enterprise Deployments

OBAIS Marks a Historic Milestone with Nasdaq Times Square Feature, Reinforcing Its Web3 Leadership

State Grid Ningxia Electric Power Co., Ltd. Guyuan Branch Conducts "3.15" Consumer Rights Protection Day Campaign

GUYUAN,China,March 17,2025-- In order to effectively safeguard the legitimate rights and interests of consumers and enhance the quality of power supply services,on March 14,State Grid Ningxia Electric

VINSSEN Acquires AIP Certification for Korea's First Hydrogen Propulsion Tugboat

SEOUL,South Korea,March 17,2025-- VINSSEN,maritime decarbonization technology specialist focused on hydrogen fuel cells and supporting systems,has received the Approval in Principle (AIP) certificatio

dsm-firmenich scents the Swiss and Dutch Pavilions at Expo 2025 in Osaka

Presenting bespoke fragrances by Master Perfumer Wessel-Jan Kos and Perfumer Coralie Spicher KAISERAUGST,Switzerland andMAASTRICHT,Netherlands,March 17,2025-- dsm-firmenich,innovators in nutrition,he

AIM Vaccine reported a significant reduction in losses for 2024, with several major products set to launch that are expected to drive substantial revenue growth

HONG KONG,March 17,2025-- AIM Vaccine Co.,Ltd. (06660.HK),a leading PRC vaccine company,published an announcement on March 17,2025,the company\'s performance in 2024 showed a significant reduction in

Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

HONG KONG,March 17,2025--Akeso Inc. (9926.HK) announced that its innovative,self-developed anti-PD-1 monoclonal antibody,penpulimab,has been officially approved by the National Medical Products Admini

GoEnhanceAI Releases Video-to-Video V4 with 30+ Styles and Public API Access

SHERIDAN,Wyo.,March 17,2025-- GoEnhanceAI,a leading AI video generation platform,has launched its fourth-generation video-to-video technology,marking a major leap forward in AI-powered video creation.